The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...

From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, scientists were able to identify patterns of neurodegeneration and create metrics ...

We spend billions searching for the cures to chronic illnesses while neglecting research that could make the daily lives of ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...

Tyaisha Blount-Dillon dealt with symptoms of Parkinson’s for most of her life but she didn’t get a life-changing diagnosis of Parkinson’s disease until her late 20s. After the diagnosis ...

The study, published Tuesday in The Lancet, is bad news for the half million Americans who have been diagnosed with Parkinson’s disease. Symptoms include tremors, stiffness and difficulty with ...

Conductor Daniel Barenboim says he has been diagnosed with Parkinson’s disease Conductor Daniel Barenboim says he has been ...

There was no improvement in symptoms; no slowing of ... into GLP-1 drugs for Alzheimer’s disease, as some researchers have ...

Ozzy Osbourne shares a heartbreaking update on his Sirius XM radio show about his Parkinson's diagnosis. The rocker tells his fans, 'I can’t walk, but you know what I was thinking over the holidays?

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease ... found no improvement in symptoms or slowed disease progression.